These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16845706

  • 1. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies.
    Harel L, Sandborg C, Lee T, von Scheven E.
    J Rheumatol; 2006 Sep; 33(9):1873-7. PubMed ID: 16845706
    [Abstract] [Full Text] [Related]

  • 2. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC, Lau CS, Wong RW.
    J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
    [Abstract] [Full Text] [Related]

  • 3. Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.
    Padovan M, Castellino G, Bortoluzzi A, Caniatti L, Trotta F, Govoni M.
    Rheumatol Int; 2012 Jan; 32(1):129-35. PubMed ID: 20676648
    [Abstract] [Full Text] [Related]

  • 4. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE, Londino AV, Kwoh CK, Medsger TA, Manzi S.
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [Abstract] [Full Text] [Related]

  • 5. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S, Gupta MK, Ahluwalia J, Singh P, Malhi P.
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [Abstract] [Full Text] [Related]

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 7. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR.
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [Abstract] [Full Text] [Related]

  • 8. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
    Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG, AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators.
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
    [Abstract] [Full Text] [Related]

  • 9. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations.
    Tincani A, Brey R, Balestrieri G, Vitali C, Doria A, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A, Bombardieri S.
    Clin Exp Rheumatol; 1996 Jan; 14 Suppl 16():S23-9. PubMed ID: 9049450
    [Abstract] [Full Text] [Related]

  • 10. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.
    de Bandt M, Benali K, Guillevin L, Hachulla E, Job C, Fautrel B, Fournié G, Bonnet C, Fournié B, Le Goff P, Jorgensen C, Meyer O.
    J Rheumatol; 1999 Jan; 26(1):91-6. PubMed ID: 9918247
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS, Kim KE, Kim JM, Han JY, Chung WT, Kim KH.
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [Abstract] [Full Text] [Related]

  • 13. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
    Riancho-Zarrabeitia L, Martínez-Taboada VM, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Mena Vázquez N, Calvo-Alén J, Menor Almagro R, Tomero Muriel E, Uriarte Isacelaya E, Boteanu A, Andres M, Freire González M, Santos Soler G, Ruiz-Lucea ME, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo Vila V, Raya E, Narváez J, Expósito L, Hernández Beriaín JA, Horcada L, Aurrecoechea E, Pego Reigosa JM.
    Clin Exp Rheumatol; 2021 Feb; 39(3):555-563. PubMed ID: 32828148
    [Abstract] [Full Text] [Related]

  • 14. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M, Meyer O, Bourgeois P, Palazzo E, Nicaise P, Labarre C, Kahn MF.
    Clin Exp Rheumatol; 1993 Feb; 11(4):373-9. PubMed ID: 8403581
    [Abstract] [Full Text] [Related]

  • 15. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R.
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [Abstract] [Full Text] [Related]

  • 17. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
    Fischer K, Brzosko M, Walecka A, Ostanek L, Sawicki M.
    Pol Arch Med Wewn; 2007 Jan; 117 Suppl():13-7. PubMed ID: 18778013
    [Abstract] [Full Text] [Related]

  • 18. A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus.
    Avcin T, Benseler SM, Tyrrell PN, Cucnik S, Silverman ED.
    Arthritis Rheum; 2008 Feb 15; 59(2):206-13. PubMed ID: 18240179
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.
    Clin Exp Immunol; 2018 Oct 15; 194(1):27-38. PubMed ID: 30208508
    [Abstract] [Full Text] [Related]

  • 20. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
    Yelnik CM, Porter TF, Branch DW, Laskin CA, Merrill JT, Guerra MM, Lockshin MD, Buyon JP, Petri M, Sammaritano LR, Stephenson MD, Kim MY, Salmon JE.
    Arthritis Rheumatol; 2016 Aug 15; 68(8):1964-9. PubMed ID: 26990620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.